Early Prediction of Placenta Accreta by 2 Dimensional Transvaginal Ultrasound and Color Doppler

Assiut University1 site in 1 country148 target enrollmentJanuary 1, 2017

ConditionsPlacenta Accreta

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Placenta Accreta
Sponsor: Assiut University
Enrollment: 148
Locations: 1
Primary Endpoint: Confirmation of occurrence of placenta accreta during delivery.
Status: Completed
Last Updated: 5 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

Placenta accreta is a substantially life threatening condition and one of the causes of maternal morbidity and mortality in the world. According to study done in United Kingdom, The estimated incidence of placenta accreta/increta/percreta was 1.7 per 10,000 maternities overall and 577 per 10,000 in women with both a previous cesarean delivery and placenta previa. in a tertiary south Italian center, The incidence increased from 0.12% during the 1970s, to 0.31% during the 2000s.While in United States of America, the prevalence of placenta accreta was 3.7 per 1000 deliveries.

Registry

clinicaltrials.gov

Start Date

January 1, 2017

End Date

March 31, 2020

Last Updated

5 years ago

Study Type

Observational

Sex

Female

Investigators

Sponsor

Assiut University

Responsible Party

Principal Investigator

Ahmed Mohamed Abbas

clinical professor

Assiut University

Eligibility Criteria

Inclusion Criteria

•Low implantation of the gestational sac (\<4 cm from external os) by transvaginal ultrasound
•Presence of placental lakes by transvaginal ultrasound
•Disruption of placental-myometrial interface by transvaginal ultrasound
•Trophoblast overlapping a uterine scar (Cesarean section, myomectomy) by transvaginal ultrasound
•Intraplacental dilated vessels by Doppler ultrasound
•Turbulent blood flows by Doppler ultrasound
•Greatly increased periplacental vascularity by Doppler ultrasound